U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"What can be more palpably absurd than the prospect held out of locomotives traveling twice as fast as stagecoaches?"

The Quarterly Review ; March edition, 1825

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 536/4.4 - Aescin or derivative


Subclass of Class 536 - Organic compounds -- part of the class 532-570 series
Definition: Products which consist of a mixture of sapogenin glycosides
No. of patents: 10
Last issue date: 06/28/2005


NumberTitleIssue Date
6911325Process for the preparation of derivatives of Ruscus aculeatus steroid glycosides by enzymatic hydrolysis
A process for the preparation of desglucodesrhamnoruscin which comprises the enzymatic hydrolysis of Ruscus Aculeatus steroid glycosides (ruscosaponins) by means of crude hydrolases from aspergillus niger. ...
06/28/2005
6730661Nutritional composition which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions
The present invention relates to the use of one or more non-digestible polysaccharides selected from the group consisting of dextrans having a molecular weight of 8 kD to 40,000 kD, hydrolysed (gluco)mannans having a molecular weight of 0.5 kD to 1,000 kD and hydrol...
05/04/2004
5658793Pseudomonas aeruginosa and its use in a process for the biotechnological preparation of L-rhamnose
Bacterial strains are capable of the formation of rhamnolipids, which they generate in the culture solution. If bacteria of the type Pseudomonas aeruginosa are employed for the fermentation, these microorganisms synthesize rhamnolipids in a concentration ...
08/19/1997
5527890Derivatives of triterpenoid acids and uses thereof
Triterpenoid acid derivatives are described that exhibit dual pharmacophobic activities, specifically selectin ligand and leukotriene biosynthetic inhibitory activities, and that thus have significant applications for the treatment or prevention of certai...
06/18/1996
5158772Unique bacterial polysaccharide polymer gel in cosmetics, pharmaceuticals and foods
Topical compositions for application to the skin comprising a topically active agent which may be a cosmetic agent or a therapeutic agent, and a small, but carrier effective amount of a microbial polysaccharide polymer gel which is a beta-1,3 glucan-type ...
10/27/1992
5079232Compound KS-505 useful for improving cerebral function
A new compound designated KS-505 having amnesia-inhibiting activity may be prepared by fermentation of a suitable strain of Streptomyces, preferably Streptomyces argenteolus A-2 (FERM BP-2065). The compound is thought to have the structure: ##STR1##...
01/07/1992
4959355Method of inhibiting osmotic water flow
This invention provides a method of inhibiting osmotic water flow across mammalian cell membranes which involves contacting the water channels of the cell membranes with an effective amount of a glucose transport blocker or of digitonin so as to inhibit o...
09/25/1990
4918171Saikosaponin derivatives, their production and use
A phosphate ester of saikosaponin a, b1, b2, c, d or h or saikogenin A, C or D, or a pharmaceutically acceptable salt thereof, which exhibits potent antiinflammatory activity against adjuvant arthritis and then can be used safely as ...
04/17/1990
4428876Process for isolating saponins and flavonoids from leguminous plants
A process for isolating saponins and flavonoids from leguminous plant which comprises extracting a part or the whole of the said plant with an aqueous alkaline solution, separating the extract from insoluble matters comprising fibrous materials, applying ...
01/31/1984
4101652Pharmaceutically active complexes and pharmaceutical compositions containing eascin and sterols
Complexes of saponins with sterols are disclosed which possess the pharmaceutical activity of the free saponins, but which have reduced side-effects. Also disclosed are pharmaceutical compositions containing the complexes....
07/18/1978
 
Sign InRegister
Username  
Password   
forgot password?